Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002593 · ClinicalTrials.gov registry record · Phase 3
S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed
A Phase 3 study, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,135
- Enrollment target
NCT00002593: Completed Phase 3 study, sponsored by SWOG Cancer Research Network.
NCT00002593 is a Phase 3 study that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 1,135 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (47% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002593, a Phase 3 study, has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,135 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving drugs in different ways may kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy given in different ways in treating patients with surgically removed stage II or stage III colon cancer at high risk of recurrence.
Interventions
- DRUG fluorouracil
- DRUG leucovorin calcium
- DRUG levamisole hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,135 participants |
| Start Date | 1994-12 |
| Est. Completion | 2005-03 |
| Phase | Phase 3 |
What the finished NCT00002593 record still lists
NCT00002593 is an interventional study that assigns participants to a tested intervention. Its 1,135 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (47% higher).
The record links to 0 conditions, and to 3 interventions - of which fluorouracil is the first listed.
NCT00002593 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002593 about?
NCT00002593 is a clinical study titled "S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving drugs in different ways may kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy given ...
What is the current status of trial NCT00002593?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,135 participants. The study started on 1994-12. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00002593?
The interventions under investigation include: fluorouracil (DRUG), leucovorin calcium (DRUG), levamisole hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00002593?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00002593's enrollment target sits among peer trials
1,135 243rd of 2000 higher than 1,757 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05894967 · 1,140 participants · NA
Moderators and Mediators of Perceptual Learning
- NCT06532487 · 1,140 participants · NA
Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities
- NCT06445062 · 1,130 participants · Phase 1
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- NCT06746129 · 1,126 participants · Phase 3
Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few Embryos
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia